Z Q Hu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Z Q Hu

Showing results (61-70 of 63) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 63 results.

Cell Death & Disease|April 22, 2016

Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signalingP-F Zhang, K-S Li, Y-H Shen, et al.

Hernia : the Journal of Hernias and Abdominal Wall Surgery|November 1, 2015

Femoral & ExperimentalT Cox, C Huntington, L Blair, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023

Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III studyX Q Yan, M J Ye, Q Zou, et al.

Pageof 7

Search research articles

Showing results (61-70 of 63) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 63 results.

Cell Death & Disease|April 22, 2016

Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signalingP-F Zhang, K-S Li, Y-H Shen, et al.

Hernia : the Journal of Hernias and Abdominal Wall Surgery|November 1, 2015

Femoral & ExperimentalT Cox, C Huntington, L Blair, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023

Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III studyX Q Yan, M J Ye, Q Zou, et al.

Pageof 7